Golden
Amaryllis Nucleics

Amaryllis Nucleics

Amaryllis Nucleics develops products to speed up RNA sequencing for the advancement of cancer diagnostics, pharmaceutical development and food security.

Amaryllis Nucleics is a spinoff from University of California-Davis. The company aims to democratize RNA sequencing and they are proponents of open science and open-source software. Their method for RNA-seq library synthesis takes advantage of a phenomenon called DNA breathing to capture the 5’ adapter.

Amarlyllis Nucleics is developing sequencing technology for diagnostics and epidemiology. Amaryllis Nucleics is developing a universal viral RNA detection kit that would detect COVID, Influenza, and other viral infections in the same test. The test would also detect and track mutations. The kit will use next-generation sequencing technology on a type of machine that can run thousands of samples per day.

Timeline

People

Name
Role
LinkedIn

Brad Townsley

Founder

Mike Covington

Founder

Further reading

Title
Author
Link
Type
Date
+ Add new row

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row

References